• Research.

    Progress begins with an idea. Through rigorous analysis we develop tools to help humanity, always the primary motivation for our research.

    Using targeted delivery methods and controlled dosing technology, our processes promote increased solubility/ absorption of these molecules.

    Working closely with with our extensive network of research institutions, universities, clinical laboratories, hospital and healthcare systems, insurance companies, contract research organizations, and the pharmaceutical industry, we are a trusted partner in the advancement in psychedelic medicine.

  • Cultivation & Manufacturing.

    Psychedelics are the next frontier of mental health. Ensuring that manufacturing and extraction capability meets growing demand is critical to ensuring researchers, and eventually patients, have access to consistent, pure chemicals and APIs.

    We intend to create state of the art, comprehensive, scalable systems for cultivating and manufacturing psychedelic molecules using uncompromising manufacturing protocols at a GMP compliant manufacturing facility dedicated exclusively to the production of psychedelics

  • Distribution.

    Already an experienced and reliable distribution and supply chain partner, we will leverage and expand our our existing network to ensure patients, clinicians, and researchers, and institutions have consistent access to pharmaceutical-grade molecules, compounds and extracts.

    As laws and minds continue to change, we will expand our output and distribution channels to include new products, markets, and customers. We will evolve in response to the needs of our customers and communities.

  • Purity.

    Utilizing the most advanced extraction, manufacturing, and storage techniques (cultivation, pre-formulation, formulation, extraction and purification of botanical extracts for commercialization), we ensure the efficacy, safety, and consistency of our processes.

  • Innovation.

    There is an art and science to manufacturing psychedelic molecules. We will amass a diverse portfolio of differentiated compounds, and eventually a pipeline of proprietary analogs, derivatives, synthetics. With a focus on stability, bioavailability, potency and duration, we are developing new and improved chemical entities, novel delivery methods, and a comprehensive catalog of active pharmaceutical ingredients.

  • Therapy.

    With novel molecules, effective formulations, and innovative delivery systems, our goal is ultimately to help clinicians and medical professionals attain the best possible health outcomes for patients. By extracting and manufacturing safe and effective APIs for the treatment of a range of psychiatric and substance use disorders and conditions (such as depression, post-traumatic stress disorder, anxiety, and addiction), we are changing lives.